Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium.
Saved in:
| Title: | Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium. |
|---|---|
| Authors: | Byonanebye DM; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.; School of Public Health, Makerere University, Kampala, Uganda., Polizzotto MN; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Neesgaard B; CHIP, Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Sarcletti M; Department of Dermatology, Venerology and Allergology, Medical University Innsbruck, Innsbruck, Austria., Matulionyte R; Department of Infectious Diseases and Dermatovenerology, Faculty of Medicine, Vilnius University Hospital Santaros Klinikos, Vilnius University, Vilnius, Lithuania., Braun DL; Division of Infectious Diseases and Hospital Epidemiology, Switzerland Swiss HIV Cohort Study (SHCS), Institute of Medical Virology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Castagna A; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milano, Italy., de Wit S; CHU Saint Pierre, Infectious Diseases, Université Libre de Bruxelles, Brussels, Belgium., Wit F; AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort, HIV Monitoring Foundation, Amsterdam, The Netherlands., Fontas E; Nice HIV Cohort, Université Côte d'Azur et Centre Hospitalier Universitaire, Nice, France., Vehreschild JJ; Medical Department 2, Hematology/Oncology, University Hospital of Frankfurt, Frankfurt, Germany.; Department I for Internal Medicine, University Hospital of Cologne, Cologne, Germany., Vesterbacka J; Swedish InfCare HIV Cohort, Karolinska University Hospital, Huddinge, Sweden., Greenberg L; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, UK., Hatleberg C; CHIP, Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Garges H; ViiV Healthcare, RTP, North Carolina, USA., Gallant J; Gilead Sciences, Foster City, California, USA., Volny Anne A; EATG European AIDS Treatment Group, Brussels, Belgium., Öllinger A; CHIP, Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Mozer-Lisewska I; Poznan University of Medical Sciences, Poznan, Poland., Surial B; Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Spagnuolo V; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milano, Italy., Necsoi C; CHU Saint Pierre, Infectious Diseases, Université Libre de Bruxelles, Brussels, Belgium., van der Valk M; AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort, HIV Monitoring Foundation, Amsterdam, The Netherlands.; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., Mocroft A; CHIP, Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, UK., Law M; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Ryom L; CHIP, Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Petoumenos K; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia. |
| Corporate Authors: | RESPOND study group |
| Source: | HIV medicine [HIV Med] 2022 Sep; Vol. 23 (8), pp. 895-910. Date of Electronic Publication: 2022 Mar 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293 (Electronic) Linking ISSN: 14642662 NLM ISO Abbreviation: HIV Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35233903 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Byonanebye+DM%22">Byonanebye DM</searchLink>; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.; School of Public Health, Makerere University, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Polizzotto+MN%22">Polizzotto MN</searchLink>; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Neesgaard+B%22">Neesgaard B</searchLink>; CHIP, Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Sarcletti+M%22">Sarcletti M</searchLink>; Department of Dermatology, Venerology and Allergology, Medical University Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Matulionyte+R%22">Matulionyte R</searchLink>; Department of Infectious Diseases and Dermatovenerology, Faculty of Medicine, Vilnius University Hospital Santaros Klinikos, Vilnius University, Vilnius, Lithuania.<br /><searchLink fieldCode="AU" term="%22Braun+DL%22">Braun DL</searchLink>; Division of Infectious Diseases and Hospital Epidemiology, Switzerland Swiss HIV Cohort Study (SHCS), Institute of Medical Virology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Castagna+A%22">Castagna A</searchLink>; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22de+Wit+S%22">de Wit S</searchLink>; CHU Saint Pierre, Infectious Diseases, Université Libre de Bruxelles, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Wit+F%22">Wit F</searchLink>; AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort, HIV Monitoring Foundation, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Fontas+E%22">Fontas E</searchLink>; Nice HIV Cohort, Université Côte d'Azur et Centre Hospitalier Universitaire, Nice, France.<br /><searchLink fieldCode="AU" term="%22Vehreschild+JJ%22">Vehreschild JJ</searchLink>; Medical Department 2, Hematology/Oncology, University Hospital of Frankfurt, Frankfurt, Germany.; Department I for Internal Medicine, University Hospital of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Vesterbacka+J%22">Vesterbacka J</searchLink>; Swedish InfCare HIV Cohort, Karolinska University Hospital, Huddinge, Sweden.<br /><searchLink fieldCode="AU" term="%22Greenberg+L%22">Greenberg L</searchLink>; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Hatleberg+C%22">Hatleberg C</searchLink>; CHIP, Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Garges+H%22">Garges H</searchLink>; ViiV Healthcare, RTP, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Gallant+J%22">Gallant J</searchLink>; Gilead Sciences, Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Volny+Anne+A%22">Volny Anne A</searchLink>; EATG European AIDS Treatment Group, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Öllinger+A%22">Öllinger A</searchLink>; CHIP, Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Mozer-Lisewska+I%22">Mozer-Lisewska I</searchLink>; Poznan University of Medical Sciences, Poznan, Poland.<br /><searchLink fieldCode="AU" term="%22Surial+B%22">Surial B</searchLink>; Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Spagnuolo+V%22">Spagnuolo V</searchLink>; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Necsoi+C%22">Necsoi C</searchLink>; CHU Saint Pierre, Infectious Diseases, Université Libre de Bruxelles, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22van+der+Valk+M%22">van der Valk M</searchLink>; AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort, HIV Monitoring Foundation, Amsterdam, The Netherlands.; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Mocroft+A%22">Mocroft A</searchLink>; CHIP, Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Law+M%22">Law M</searchLink>; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Ryom+L%22">Ryom L</searchLink>; CHIP, Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Petoumenos+K%22">Petoumenos K</searchLink>; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22RESPOND+study+group%22">RESPOND study group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100897392%22">HIV medicine</searchLink> [HIV Med] 2022 Sep; Vol. 23 (8), pp. 895-910. <i>Date of Electronic Publication: </i>2022 Mar 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100897392 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-1293 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214642662%22">14642662 </searchLink><i>NLM ISO Abbreviation: </i>HIV Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35233903 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/hiv.13273 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 895 Titles: – TitleFull: Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Byonanebye DM – PersonEntity: Name: NameFull: Polizzotto MN – PersonEntity: Name: NameFull: Neesgaard B – PersonEntity: Name: NameFull: Sarcletti M – PersonEntity: Name: NameFull: Matulionyte R – PersonEntity: Name: NameFull: Braun DL – PersonEntity: Name: NameFull: Castagna A – PersonEntity: Name: NameFull: de Wit S – PersonEntity: Name: NameFull: Wit F – PersonEntity: Name: NameFull: Fontas E – PersonEntity: Name: NameFull: Vehreschild JJ – PersonEntity: Name: NameFull: Vesterbacka J – PersonEntity: Name: NameFull: Greenberg L – PersonEntity: Name: NameFull: Hatleberg C – PersonEntity: Name: NameFull: Garges H – PersonEntity: Name: NameFull: Gallant J – PersonEntity: Name: NameFull: Volny Anne A – PersonEntity: Name: NameFull: Öllinger A – PersonEntity: Name: NameFull: Mozer-Lisewska I – PersonEntity: Name: NameFull: Surial B – PersonEntity: Name: NameFull: Spagnuolo V – PersonEntity: Name: NameFull: Necsoi C – PersonEntity: Name: NameFull: van der Valk M – PersonEntity: Name: NameFull: Mocroft A – PersonEntity: Name: NameFull: Law M – PersonEntity: Name: NameFull: Ryom L – PersonEntity: Name: NameFull: Petoumenos K IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2022 Sep Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1468-1293 Numbering: – Type: volume Value: 23 – Type: issue Value: 8 Titles: – TitleFull: HIV medicine Type: main |
| ResultId | 1 |